Natural compounds targeting major cell signaling pathways: a novel paradigm for osteosarcoma therapy
Tóm tắt
Osteosarcoma is the most common primary bone cancer affecting children and adolescents worldwide. Despite an incidence of three cases per million annually, it accounts for an inordinate amount of morbidity and mortality. While the use of chemotherapy (cisplatin, doxorubicin, and methotrexate) in the last century initially resulted in marginal improvement in survival over surgery alone, survival has not improved further in the past four decades. Patients with metastatic osteosarcoma have an especially poor prognosis, with only 30% overall survival. Hence, there is a substantial need for new therapies. The inability to control the metastatic progression of this localized cancer stems from a lack of complete knowledge of the biology of osteosarcoma. Consequently, there has been an aggressive undertaking of scientific investigation of various signaling pathways that could be instrumental in understanding the pathogenesis of osteosarcoma. Here, we review these cancer signaling pathways, including Notch, Wnt, Hedgehog, phosphatidylinositol-4,5-bisphosphate 3-kinase (PI3K)/AKT, and JAK/STAT, and their specific role in osteosarcoma. In addition, we highlight numerous natural compounds that have been documented to target these pathways effectively, including curcumin, diallyl trisulfide, resveratrol, apigenin, cyclopamine, and sulforaphane. We elucidate through references that these natural compounds can induce cancer signaling pathway manipulation and possibly facilitate new treatment modalities for osteosarcoma.
Tài liệu tham khảo
citation_journal_title=J Am Acad Orthop Surg; citation_title=Osteosarcoma; citation_author=PJ Messerschmitt, RM Garcia, FW Abdul-Karim, EM Greenfield, PJ Getty; citation_volume=17; citation_publication_date=2009; citation_pages=515-527; citation_doi=10.5435/00124635-200908000-00005; citation_id=CR1
citation_journal_title=Am J Clin Pathol; citation_title=Osteosarcoma: anatomic and histologic variants; citation_author=MJ Klein, GP Siegal; citation_volume=125; citation_publication_date=2006; citation_pages=555-581; citation_doi=10.1309/UC6KQHLD9LV2KENN; citation_id=CR2
citation_journal_title=Orphanet J Rare Dis; citation_title=Osteosarcoma (osteogenic sarcoma); citation_author=P Picci; citation_volume=2; citation_publication_date=2007; citation_pages=6; citation_doi=10.1186/1750-1172-2-6; citation_id=CR3
citation_journal_title=Curr Opin Pharmacol; citation_title=Recent advances in osteosarcoma; citation_author=SM Botter, D Neri, B Fuchs; citation_volume=16; citation_publication_date=2014; citation_pages=15-23; citation_doi=10.1016/j.coph.2014.02.002; citation_id=CR4
citation_journal_title=Sarcoma; citation_title=Osteosarcoma: evolution of treatment paradigms; citation_author=N Jaffe, A Puri, H Gelderblom; citation_volume=2013; citation_publication_date=2013; citation_pages=203531; citation_doi=10.1155/2013/203531; citation_id=CR5
citation_journal_title=J Surg Oncol; citation_title=High grade osteosarcoma of the extremities with lung metastases at presentation: treatment with neoadjuvant chemotherapy and simultaneous resection of primary and metastatic lesions; citation_author=G Bacci, M Rocca, M Salone, A Balladelli, S Ferrari, E Palmerini, C Forni, A Briccoli; citation_volume=98; citation_publication_date=2008; citation_pages=415-420; citation_doi=10.1002/jso.21140; citation_id=CR6
citation_journal_title=Clin Chim Acta; citation_title=PI3K/Akt signaling in osteosarcoma; citation_author=J Zhang, XH Yu, YG Yan, C Wang, WJ Wang; citation_volume=444; citation_publication_date=2015; citation_pages=182-192; citation_doi=10.1016/j.cca.2014.12.041; citation_id=CR7
citation_journal_title=Cell; citation_title=The canonical Notch signaling pathway: unfolding the activation mechanism; citation_author=R Kopan, MX Ilagan; citation_volume=137; citation_publication_date=2009; citation_pages=216-233; citation_doi=10.1016/j.cell.2009.03.045; citation_id=CR8
citation_journal_title=Nature; citation_title=Mutations in NOTCH1 cause aortic valve disease; citation_author=V Garg, AN Muth, JF Ransom, MK Schluterman, R Barnes, IN King, PD Grossfeld, D Srivastava; citation_volume=437; citation_publication_date=2005; citation_pages=270-274; citation_doi=10.1038/nature03940; citation_id=CR9
citation_journal_title=Hum Mol Genet; citation_title=Notch signaling and inherited disease syndromes; citation_author=T Gridley; citation_volume=12 Spec No 1; citation_publication_date=2003; citation_pages=R9-13; citation_doi=10.1093/hmg/ddg052; citation_id=CR10
citation_journal_title=Sci STKE; citation_title=Notch signaling pathway; citation_author=M Ehebauer, P Hayward, A Martinez-Arias; citation_volume=2006; citation_publication_date=2006; citation_pages=cm7; citation_doi=10.1126/stke.3642006cm7; citation_id=CR11
citation_journal_title=Methods Enzymol; citation_title=Roles of O-fucosyltransferase 1 and O-linked fucose in notch receptor function; citation_author=T Okajima, T Matsuda; citation_volume=417; citation_publication_date=2006; citation_pages=111-126; citation_doi=10.1016/S0076-6879(06)17009-3; citation_id=CR12
citation_journal_title=J Biol Chem; citation_title=Active gamma-secretase complexes contain only one of each component; citation_author=T Sato, TS Diehl, S Narayanan, S Funamoto, Y Ihara, B Strooper, H Steiner, C Haass, MS Wolfe; citation_volume=282; citation_publication_date=2007; citation_pages=33985-33993; citation_doi=10.1074/jbc.M705248200; citation_id=CR13
citation_journal_title=Dev Biol; citation_title=Notch signaling: from the outside in; citation_author=JS Mumm, R Kopan; citation_volume=228; citation_publication_date=2000; citation_pages=151-165; citation_doi=10.1006/dbio.2000.9960; citation_id=CR14
citation_journal_title=Blood; citation_title=Recent insights into the role of Notch signaling in tumorigenesis; citation_author=KG Leong, A Karsan; citation_volume=107; citation_publication_date=2006; citation_pages=2223-2233; citation_doi=10.1182/blood-2005-08-3329; citation_id=CR15
citation_journal_title=Orthop Clin North Am; citation_title=Update on survival in osteosarcoma; citation_author=ME Anderson; citation_volume=47; citation_publication_date=2016; citation_pages=283-292; citation_doi=10.1016/j.ocl.2015.08.022; citation_id=CR16
citation_journal_title=Br J Cancer; citation_title=Hairy/enhancer-of-split related with YRPW motif protein 1 promotes osteosarcoma metastasis via matrix metallopeptidase 9 expression; citation_author=A Tsuru, T Setoguchi, Y Matsunoshita, H Nagao-Kitamoto, S Nagano, M Yokouchi, S Maeda, Y Ishidou, T Yamamoto, S Komiya; citation_volume=112; citation_publication_date=2015; citation_pages=1232-1240; citation_doi=10.1038/bjc.2015.84; citation_id=CR17
citation_journal_title=Cancer Cell; citation_title=Tumor-derived JAGGED1 promotes osteolytic bone metastasis of breast cancer by engaging notch signaling in bone cells; citation_author=N Sethi, X Dai, CG Winter, Y Kang; citation_volume=19; citation_publication_date=2011; citation_pages=192-205; citation_doi=10.1016/j.ccr.2010.12.022; citation_id=CR18
citation_journal_title=Front Oncol; citation_title=Notch signaling is associated with ALDH activity and an aggressive metastatic phenotype in murine osteosarcoma cells; citation_author=X Mu, C Isaac, N Greco, J Huard, K Weiss; citation_volume=3; citation_publication_date=2013; citation_pages=143; citation_doi=10.3389/fonc.2013.00143; citation_id=CR19
citation_journal_title=Hum Pathol; citation_title=MicroRNA-199b-5p is involved in the Notch signaling pathway in osteosarcoma; citation_author=KY Won, YW Kim, HS Kim, SK Lee, WW Jung, YK Park; citation_volume=44; citation_publication_date=2013; citation_pages=1648-1655; citation_doi=10.1016/j.humpath.2013.01.016; citation_id=CR20
citation_journal_title=Cancer Treat Res; citation_title=How the NOTCH pathway contributes to the ability of osteosarcoma cells to metastasize; citation_author=DP Hughes; citation_volume=152; citation_publication_date=2009; citation_pages=479-496; citation_doi=10.1007/978-1-4419-0284-9_28; citation_id=CR21
citation_journal_title=J Cell Biochem; citation_title=Wnt10b activates the Wnt, notch, and NFkappaB pathways in U2OS osteosarcoma cells; citation_author=UI Modder, MJ Oursler, S Khosla, DG Monroe; citation_volume=112; citation_publication_date=2011; citation_pages=1392-1402; citation_doi=10.1002/jcb.23048; citation_id=CR22
citation_journal_title=Hum Mol Genet; citation_title=Notch signaling contributes to the pathogenesis of human osteosarcomas; citation_author=F Engin, T Bertin, O Ma, MM Jiang, L Wang, RE Sutton, LA Donehower, B Lee; citation_volume=18; citation_publication_date=2009; citation_pages=1464-1470; citation_doi=10.1093/hmg/ddp057; citation_id=CR23
citation_journal_title=Mol Med Rep; citation_title=Resveratrol inhibits canonical Wnt signaling in human MG-63 osteosarcoma cells; citation_author=Y Zou, J Yang, D Jiang; citation_volume=12; citation_publication_date=2015; citation_pages=7221-7226; citation_id=CR24
citation_journal_title=Organogenesis; citation_title=Wnt signal transduction pathways; citation_author=Y Komiya, R Habas; citation_volume=4; citation_publication_date=2008; citation_pages=68-75; citation_doi=10.4161/org.4.2.5851; citation_id=CR25
citation_journal_title=Dev Cell; citation_title=Wnt/beta-catenin signaling: components, mechanisms, and diseases; citation_author=BT MacDonald, K Tamai, X He; citation_volume=17; citation_publication_date=2009; citation_pages=9-26; citation_doi=10.1016/j.devcel.2009.06.016; citation_id=CR26
Wang DZ, Gao JF, Jing SF, Wei H, Huang XY, Li CD. Antitumor effect of docetaxel in osteosarcoma by the inhibition of Wnt signal channel. Drug Res (Stuttg). 2014;65(11):597–601.
Zhao S, Kurenbekova L, Gao Y, Roos A, Creighton CJ, Rao P, Hicks J, Man TK, Lau C, Brown AM, et al. NKD2, a negative regulator of Wnt signaling, suppresses tumor growth and metastasis in osteosarcoma. Oncogene. 2015;34(39):5069–79.
citation_journal_title=Genet Mol Res; citation_title=Wnt1-induced MAFK expression promotes osteosarcoma cell proliferation; citation_author=R Wang, J Zheng, DS Zhang, YH Yang, ZF Zhao; citation_volume=14; citation_publication_date=2015; citation_pages=7315-7325; citation_doi=10.4238/2015.July.3.7; citation_id=CR29
citation_journal_title=Cancers (Basel); citation_title=Hedgehog signaling inhibitors as anti-cancer agents in osteosarcoma; citation_author=RM Kumar, B Fuchs; citation_volume=7; citation_publication_date=2015; citation_pages=784-794; citation_doi=10.3390/cancers7020784; citation_id=CR30
citation_journal_title=Int J Mol Med; citation_title=Effect of the Hedgehog-inhibitor cyclopamine on mice with osteosarcoma pulmonary metastases; citation_author=J Warzecha, D Dinges, B Kaszap, D Henrich, I Marzi, C Seebach; citation_volume=29; citation_publication_date=2012; citation_pages=423-427; citation_id=CR31
citation_journal_title=Paediatr Drugs; citation_title=Bone sarcomas in pediatrics: progress in our understanding of tumor biology and implications for therapy; citation_author=RK Rivera-Valentin, L Zhu, DP Hughes; citation_volume=17; citation_publication_date=2015; citation_pages=257-271; citation_doi=10.1007/s40272-015-0134-4; citation_id=CR32
citation_journal_title=Int J Surg; citation_title=P53 suppresses cell proliferation, metastasis, and angiogenesis of osteosarcoma through inhibition of the PI3K/AKT/mTOR pathway; citation_author=R Song, K Tian, W Wang, L Wang; citation_volume=20; citation_publication_date=2015; citation_pages=80-87; citation_doi=10.1016/j.ijsu.2015.04.050; citation_id=CR33
citation_journal_title=Connect Tissue Res; citation_title=5,7-Dihydroxy-4′-methoxyisoflavone induces apoptosis by inhibiting the ERK and Akt pathways in human osteosarcoma cells; citation_author=X Lu, J Zhao, T Li, M Huang, J Liang, W Wei; citation_volume=56; citation_publication_date=2015; citation_pages=59-64; citation_doi=10.3109/03008207.2014.984064; citation_id=CR34
citation_journal_title=Biomed Res Int; citation_title=RLN2 is a positive regulator of AKT-2-induced gene expression required for osteosarcoma cells invasion and chemoresistance; citation_author=J Ma, H Huang, Z Han, C Zhu, B Yue; citation_volume=2015; citation_publication_date=2015; citation_pages=147468; citation_id=CR35
citation_journal_title=Ther Adv Med Oncol; citation_title=MEK and PI3K inhibition in solid tumors: rationale and evidence to date; citation_author=E Jokinen, JP Koivunen; citation_volume=7; citation_publication_date=2015; citation_pages=170-180; citation_doi=10.1177/1758834015571111; citation_id=CR36
citation_journal_title=Anticancer Res; citation_title=Ras/Raf/MEK/ERK pathway is associated with lung metastasis of osteosarcoma in an orthotopic mouse model; citation_author=Y Yu, F Luk, JL Yang, WR Walsh; citation_volume=31; citation_publication_date=2011; citation_pages=1147-1152; citation_id=CR37
citation_journal_title=J Korean Soc Menopause; citation_title=Ezrin is an essential marker for metastasis of gynecologic cancer; citation_author=SD Choi; citation_volume=18; citation_publication_date=2012; citation_pages=81-93; citation_doi=10.6118/jksm.2012.18.2.81; citation_id=CR38
citation_journal_title=Adv Exp Med Biol; citation_title=Role of ezrin in osteosarcoma metastasis; citation_author=L Ren, C Khanna; citation_volume=804; citation_publication_date=2014; citation_pages=181-201; citation_doi=10.1007/978-3-319-04843-7_10; citation_id=CR39
citation_journal_title=Chin Med J (Engl); citation_title=Ezrin promotes invasion and migration of the MG63 osteosarcoma cell; citation_author=J Zhang, J Zuo, M Lei, S Wu, X Zang, C Zhang; citation_volume=127; citation_publication_date=2014; citation_pages=1954-1959; citation_id=CR40
citation_journal_title=ScientificWorldJournal; citation_title=Correlations of ezrin expression with pathological characteristics and prognosis of osteosarcoma: a meta-analysis; citation_author=DH Zhao, J Zhu, WB Wang, F Dong, Q Zhang, HW Fan, JZ Zhang, YM Wang; citation_volume=2014; citation_publication_date=2014; citation_pages=837543; citation_id=CR41
Celik H, Hong SH, Colon-Lopez DD, Han J, Saygideger Kont Y, Minas TZ, Swift M, Paige M, Glasgow E, Toretsky JA, et al. Identification of novel ezrin inhibitors targeting metastatic osteosarcoma by screening open access malaria box. Mol Cancer Ther. 2015;14(11);2497–507.
citation_journal_title=Cancer Lett; citation_title=STAT3 activation by IL-6 from mesenchymal stem cells promotes the proliferation and metastasis of osteosarcoma; citation_author=B Tu, L Du, QM Fan, Z Tang, TT Tang; citation_volume=325; citation_publication_date=2012; citation_pages=80-88; citation_doi=10.1016/j.canlet.2012.06.006; citation_id=CR43
Cokic VP, Mitrovic-Ajtic O, Beleslin-Cokic BB, Markovic D, Buac M, Diklic M, Kraguljac-Kurtovic N, Damjanovic S, Milenkovic P, Gotic M, Raj PK. Proinflammatory Cytokine IL-6 and JAK-STAT Signaling Pathway in Myeloproliferative Neoplasms. Mediators Inflamm. 2015;2015:453020.
citation_journal_title=Ulster Med J; citation_title=JAK2 V617F: a single mutation in the myeloproliferative group of disorders; citation_author=D McLornan, M Percy, MF McMullin; citation_volume=75; citation_publication_date=2006; citation_pages=112-119; citation_id=CR45
citation_journal_title=Adv Exp Med Biol; citation_title=Curcumin: the Indian solid gold; citation_author=BB Aggarwal, C Sundaram, N Malani, H Ichikawa; citation_volume=595; citation_publication_date=2007; citation_pages=1-75; citation_doi=10.1007/978-0-387-46401-5_1; citation_id=CR46
citation_journal_title=Int J Nanomedicine; citation_title=Short communication: selective cytotoxicity of curcumin on osteosarcoma cells compared to healthy osteoblasts; citation_author=R Chang, L Sun, TJ Webster; citation_volume=9; citation_publication_date=2014; citation_pages=461-465; citation_id=CR47
citation_journal_title=Febs J; citation_title=Curcumin inhibits proliferation and invasion of osteosarcoma cells through inactivation of Notch-1 signaling; citation_author=Y Li, J Zhang, D Ma, L Zhang, M Si, H Yin, J Li; citation_volume=279; citation_publication_date=2012; citation_pages=2247-2259; citation_doi=10.1111/j.1742-4658.2012.08607.x; citation_id=CR48
citation_journal_title=Tumour Biol; citation_title=Curcumin induces osteosarcoma MG63 cells apoptosis via ROS/Cyto-C/Caspase-3 pathway; citation_author=Z Chang, J Xing, X Yu; citation_volume=35; citation_publication_date=2014; citation_pages=753-758; citation_doi=10.1007/s13277-013-1102-7; citation_id=CR49
citation_journal_title=Carcinogenesis; citation_title=Diallyl trisulfide inhibits proliferation, invasion and angiogenesis of osteosarcoma cells by switching on suppressor microRNAs and inactivating of Notch-1 signaling; citation_author=Y Li, J Zhang, L Zhang, M Si, H Yin, J Li; citation_volume=34; citation_publication_date=2013; citation_pages=1601-1610; citation_doi=10.1093/carcin/bgt065; citation_id=CR50
Ferrucci V, Boffa I, De Masi G, Zollo M. Natural compounds for pediatric cancer treatment. Naunyn Schmiedebergs Arch Pharmacol. 2016:389(2):131-49.
citation_journal_title=Drug Deliv Transl Res; citation_title=Novel strategies targeting cancer stem cells through phytochemicals and their analogs; citation_author=P Dandawate, S Padhye, A Ahmad, FH Sarkar; citation_volume=3; citation_publication_date=2013; citation_pages=165-182; citation_doi=10.1007/s13346-012-0079-x; citation_id=CR52
citation_journal_title=Front Nutr; citation_title=Anticancer molecular mechanisms of resveratrol; citation_author=EM Varoni, AF Lo Faro, J Sharifi-Rad, M Iriti; citation_volume=3; citation_publication_date=2016; citation_pages=8; citation_doi=10.3389/fnut.2016.00008; citation_id=CR53
citation_journal_title=Mech Ageing Dev; citation_title=Resveratrol induces senescence-like growth inhibition of U-2 OS cells associated with the instability of telomeric DNA and upregulation of BRCA1; citation_author=M Rusin, A Zajkowicz, D Butkiewicz; citation_volume=130; citation_publication_date=2009; citation_pages=528-537; citation_doi=10.1016/j.mad.2009.06.005; citation_id=CR54
citation_journal_title=Vopr Pitan; citation_title=Biologically active substances of plant origin. Flavonols and flavones: prevalence, dietary sourses and consumption; citation_author=VA Tutel’ian, NV Lashneva; citation_volume=82; citation_publication_date=2013; citation_pages=4-22; citation_id=CR55
citation_journal_title=Oncotarget; citation_title=Apigenin blocks IKKalpha activation and suppresses prostate cancer progression; citation_author=S Shukla, R Kanwal, E Shankar, M Datt, MR Chance, P Fu, GT MacLennan, S Gupta; citation_volume=6; citation_publication_date=2015; citation_pages=31216-31232; citation_doi=10.18632/oncotarget.4078; citation_id=CR56
citation_journal_title=Oncol Rep; citation_title=Apigenin inhibits the proliferation and invasion of osteosarcoma cells by suppressing the Wnt/beta-catenin signaling pathway; citation_author=X Liu, L Li, L Lv, D Chen, L Shen, Z Xie; citation_volume=34; citation_publication_date=2015; citation_pages=1035-1041; citation_id=CR57
citation_journal_title=Eur J Gynaecol Oncol; citation_title=Effects of cyclopamine on the biological characteristics of human breast cancer MCF-7 cell line and its mechanism; citation_author=DM Zhu, WL Xue, W Tao, JC Li; citation_volume=36; citation_publication_date=2015; citation_pages=469-472; citation_id=CR58
citation_journal_title=Zhonghua Nan Ke Xue; citation_title=Effects of cyclopamine on the proliferation and apoptosis of LNCaP cells and expression of the PCA3 gene in human prostate cancer; citation_author=ZY Lu, LD Lu, MA Liang-Hong; citation_volume=20; citation_publication_date=2014; citation_pages=213-217; citation_id=CR59
citation_journal_title=Int J Cancer; citation_title=Hedgehog signalling in colorectal tumour cells: induction of apoptosis with cyclopamine treatment; citation_author=D Qualtrough, A Buda, W Gaffield, AC Williams, C Paraskeva; citation_volume=110; citation_publication_date=2004; citation_pages=831-837; citation_doi=10.1002/ijc.20227; citation_id=CR60
citation_journal_title=J Agric Food Chem; citation_title=Cyclopamine: from cyclops lambs to cancer treatment; citation_author=ST Lee, KD Welch, KE Panter, DR Gardner, M Garrossian, CW Chang; citation_volume=62; citation_publication_date=2014; citation_pages=7355-7362; citation_doi=10.1021/jf5005622; citation_id=CR61
citation_journal_title=PLoS One; citation_title=Sulforaphane bioavailability from glucoraphanin-rich broccoli: control by active endogenous myrosinase; citation_author=JW Fahey, WD Holtzclaw, SL Wehage, KL Wade, KK Stephenson, P Talalay; citation_volume=10; citation_publication_date=2015; citation_pages=e0140963; citation_doi=10.1371/journal.pone.0140963; citation_id=CR62
citation_journal_title=Oncol Rep; citation_title=Effectiveness of sulforaphane as a radiosensitizer for murine osteosarcoma cells; citation_author=Y Sawai, H Murata, M Horii, K Koto, T Matsui, N Horie, Y Tsuji, E Ashihara, T Maekawa, T Kubo, S Fushiki; citation_volume=29; citation_publication_date=2013; citation_pages=941-945; citation_id=CR63
citation_journal_title=Nutr Cancer; citation_title=Sulforaphane induces DNA damage and mitotic abnormalities in human osteosarcoma MG-63 cells: correlation with cell cycle arrest and apoptosis; citation_author=JM FerreiradeOliveira, C Remedios, H Oliveira, P Pinto, F Pinho, S Pinho, M Costa, C Santos; citation_volume=66; citation_publication_date=2014; citation_pages=325-334; citation_doi=10.1080/01635581.2014.864777; citation_id=CR64
citation_journal_title=J Am Soc Nephrol; citation_title=Activation of Ras by receptor tyrosine kinases; citation_author=B Margolis, EY Skolnik; citation_volume=5; citation_publication_date=1994; citation_pages=1288-1299; citation_id=CR65